局部-话题@MedSci

#局部#

598篇内容 | 2682人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1406193, encodeId=d82b140619332, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=JAMA Oncol：DDGP方案 vs SMILE方案治疗新诊断的局部晚期结外自然杀伤/T细胞淋巴瘤, objectType=article, longId=730250, objectId=b725e302503d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b725e302503d, replyNumber=0, likeNumber=79, createdTime=2022-06-24, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b725e302503d, moduleTitle=JAMA Oncol：DDGP方案 vs SMILE方案治疗新诊断的局部晚期结外自然杀伤/T细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b725e302503d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406192, encodeId=fe3414061920b, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Clin Cancer Res：新型PD-L1抗体TQB2450联合安罗替尼治疗局部晚期/转移性软组织肉瘤, objectType=article, longId=729559, objectId=1586e2955944, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1586e2955944, replyNumber=0, likeNumber=92, createdTime=2022-06-16, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1586e2955944, moduleTitle=Clin Cancer Res：新型PD-L1抗体TQB2450联合安罗替尼治疗局部晚期/转移性软组织肉瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1586e2955944)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406191, encodeId=9a251406191ab, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=NEJM Evid：durvalumab联合标准化疗治疗局部晚期或转移性胆道癌, objectType=article, longId=729496, objectId=5ebee29496b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ebee29496b6, replyNumber=0, likeNumber=65, createdTime=2022-06-15, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ebee29496b6, moduleTitle=NEJM Evid：durvalumab联合标准化疗治疗局部晚期或转移性胆道癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ebee29496b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406186, encodeId=cf67140618612, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=2022 ASCO：局部区域并发症的频率及其对胆管癌患者住院结局的影响, objectType=article, longId=728371, objectId=5d5fe2837120, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d5fe2837120, replyNumber=0, likeNumber=91, createdTime=2022-06-02, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d5fe2837120, moduleTitle=2022 ASCO：局部区域并发症的频率及其对胆管癌患者住院结局的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d5fe2837120)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406187, encodeId=6fc7140618ed9, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=2022 ASCO：转移性肝内胆管癌合并肝外疾病患者的局部放射治疗可保护肝功能, objectType=article, longId=728364, objectId=da16e2836491, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da16e2836491, replyNumber=0, likeNumber=79, createdTime=2022-06-02, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da16e2836491, moduleTitle=2022 ASCO：转移性肝内胆管癌合并肝外疾病患者的局部放射治疗可保护肝功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=da16e2836491)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406189, encodeId=3dde1406189b0, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Eur J Cardiothorac Surg：胸骨深部伤口感染局部应用庆大霉素并不会缩短患者住院时间，降低死亡率, objectType=article, longId=728144, objectId=2ce3e2814433, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ce3e2814433, replyNumber=0, likeNumber=84, createdTime=2022-05-31, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ce3e2814433, moduleTitle=Eur J Cardiothorac Surg：胸骨深部伤口感染局部应用庆大霉素并不会缩短患者住院时间，降低死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2ce3e2814433)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406188, encodeId=89cb140618898, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=J Invest Dermatol：烧伤诱导的局部和全身免疫反应, objectType=article, longId=728132, objectId=63e8e2813270, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63e8e2813270, replyNumber=0, likeNumber=82, createdTime=2022-05-31, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63e8e2813270, moduleTitle=J Invest Dermatol：烧伤诱导的局部和全身免疫反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63e8e2813270)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406190, encodeId=264e1406190ce, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=ADV：Sonidegib治疗局部晚期基底细胞癌回顾性研究, objectType=article, longId=728083, objectId=7358e280834f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7358e280834f, replyNumber=0, likeNumber=68, createdTime=2022-05-30, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7358e280834f, moduleTitle=ADV：Sonidegib治疗局部晚期基底细胞癌回顾性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7358e280834f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406184, encodeId=aae31406184b4, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Mil Med：战时烧伤伤员局部治疗新方法研究, objectType=article, longId=726620, objectId=ceb1e26620a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ceb1e26620a0, replyNumber=0, likeNumber=80, createdTime=2022-05-12, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ceb1e26620a0, moduleTitle=Mil Med：战时烧伤伤员局部治疗新方法研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ceb1e26620a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406185, encodeId=7a9514061859b, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Aging Cell：绝经期全身性和局部性肥胖增加研究, objectType=article, longId=726612, objectId=1856e26612e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1856e26612e5, replyNumber=0, likeNumber=64, createdTime=2022-05-12, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1856e26612e5, moduleTitle=Aging Cell：绝经期全身性和局部性肥胖增加研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1856e26612e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406183, encodeId=a42c1406183cc, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Rhizen Pharmaceuticals AG在2022年欧洲肿瘤内科学会乳腺癌会议上公布一项进行中的Tenalisib (RP6530)治疗局部晚期或转移性乳腺癌患者II期研究的中期积极数据, objectType=article, longId=726291, objectId=eddae262914c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eddae262914c, replyNumber=0, likeNumber=38, createdTime=2022-05-08, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eddae262914c, moduleTitle=Rhizen Pharmaceuticals AG在2022年欧洲肿瘤内科学会乳腺癌会议上公布一项进行中的Tenalisib (RP6530)治疗局部晚期或转移性乳腺癌患者II期研究的中期积极数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eddae262914c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406182, encodeId=99ad140618211, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=BMC Med：阿帕替尼+奥沙利铂+卡培他滨新辅助治疗局部晚期胃癌/胃食管交界处癌, objectType=article, longId=726038, objectId=a34fe2603805, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a34fe2603805, replyNumber=0, likeNumber=72, createdTime=2022-05-04, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a34fe2603805, moduleTitle=BMC Med：阿帕替尼+奥沙利铂+卡培他滨新辅助治疗局部晚期胃癌/胃食管交界处癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a34fe2603805)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406181, encodeId=74c714061812c, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=DCR：扩大右侧结肠切除术不会降低结肠癌局部区域复发的风险, objectType=article, longId=724829, objectId=439de24829cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=439de24829cc, replyNumber=0, likeNumber=68, createdTime=2022-04-24, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=439de24829cc, moduleTitle=DCR：扩大右侧结肠切除术不会降低结肠癌局部区域复发的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=439de24829cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406180, encodeId=e1dd140618095, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=NICE推荐Bavncio (avelumab)治疗局部晚期转移性尿路上皮癌 (UC), objectType=article, longId=724472, objectId=bbc0e244722a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bbc0e244722a, replyNumber=0, likeNumber=65, createdTime=2022-04-19, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bbc0e244722a, moduleTitle=NICE推荐Bavncio (avelumab)治疗局部晚期转移性尿路上皮癌 (UC), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bbc0e244722a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406179, encodeId=5bec14061e953, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=J Dermatolog Treat：局部曲安奈德联合富血小板血浆可更好地治疗瘢痕疙瘩, objectType=article, longId=724054, objectId=e49de24054cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e49de24054cf, replyNumber=0, likeNumber=103, createdTime=2022-04-13, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e49de24054cf, moduleTitle=J Dermatolog Treat：局部曲安奈德联合富血小板血浆可更好地治疗瘢痕疙瘩, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e49de24054cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406178, encodeId=1e7914061e818, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=AACR重磅：局部晚期或转移性胃/GEJ癌患者使用抗TTX-030联合化学免疫疗法的一线治疗的安全性有效性评估, objectType=article, longId=723989, objectId=0551e2398931, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0551e2398931, replyNumber=0, likeNumber=79, createdTime=2022-04-12, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0551e2398931, moduleTitle=AACR重磅：局部晚期或转移性胃/GEJ癌患者使用抗TTX-030联合化学免疫疗法的一线治疗的安全性有效性评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0551e2398931)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406177, encodeId=9e3314061e752, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=J Allergy Clin Immunol：乌帕替尼+局部皮质激素可有效治疗特应性皮炎，效果至少持续52周, objectType=article, longId=723900, objectId=8ba5e23900f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ba5e23900f9, replyNumber=0, likeNumber=127, createdTime=2022-04-11, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ba5e23900f9, moduleTitle=J Allergy Clin Immunol：乌帕替尼+局部皮质激素可有效治疗特应性皮炎，效果至少持续52周, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ba5e23900f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406176, encodeId=308614061e675, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=BMC Cancer：局部晚期非小细胞肺癌（LA-NSCLC）放化疗后durvalumab治疗可改善患者的预后, objectType=article, longId=723788, objectId=3020e23788de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3020e23788de, replyNumber=0, likeNumber=53, createdTime=2022-04-09, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3020e23788de, moduleTitle=BMC Cancer：局部晚期非小细胞肺癌（LA-NSCLC）放化疗后durvalumab治疗可改善患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3020e23788de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406175, encodeId=5d0614061e522, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=J Dermatolog Treat：激光治疗原发性局部皮肤淀粉样变性的效果如何？, objectType=article, longId=723582, objectId=61c0e235820a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61c0e235820a, replyNumber=0, likeNumber=78, createdTime=2022-04-07, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61c0e235820a, moduleTitle=J Dermatolog Treat：激光治疗原发性局部皮肤淀粉样变性的效果如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61c0e235820a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406174, encodeId=e40214061e4c1, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Front Oncol：局部晚期或转移性食管鳞状细胞癌患者在化疗基础上联合放疗可改善患者预后, objectType=article, longId=723550, objectId=0c6ae23550d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c6ae23550d2, replyNumber=0, likeNumber=61, createdTime=2022-04-07, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c6ae23550d2, moduleTitle=Front Oncol：局部晚期或转移性食管鳞状细胞癌患者在化疗基础上联合放疗可改善患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c6ae23550d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

局部

2020-05-29

docwu2019 (审核中...)

前往app查看评论内容

#局部#

JAMA Oncol：DDGP方案 vs SMILE方案治疗新诊断的局部晚期结外自然杀伤/T细胞淋巴瘤

2022-06-24

docwu2019 (审核中...)

前往app查看评论内容

#局部#

Clin Cancer Res：新型PD-L1抗体TQB2450联合安罗替尼治疗局部晚期/转移性软组织肉瘤

2022-06-16

docwu2019 (审核中...)

前往app查看评论内容

#局部#

NEJM Evid：durvalumab联合标准化疗治疗局部晚期或转移性胆道癌

2022-06-15

chg122 (审核中...)

前往app查看评论内容

#局部#

2022 ASCO：局部区域并发症的频率及其对胆管癌患者住院结局的影响

2022-06-02

chg122 (审核中...)

前往app查看评论内容

#局部#

2022 ASCO：转移性肝内胆管癌合并肝外疾病患者的局部放射治疗可保护肝功能

2022-06-02

chg122 (审核中...)

前往app查看评论内容

#局部#

Eur J Cardiothorac Surg：胸骨深部伤口感染局部应用庆大霉素并不会缩短患者住院时间，降低死亡率

2022-05-31

chg122 (审核中...)

前往app查看评论内容

#局部#

J Invest Dermatol：烧伤诱导的局部和全身免疫反应

2022-05-31

docwu2019 (审核中...)

前往app查看评论内容

#局部#

ADV：Sonidegib治疗局部晚期基底细胞癌回顾性研究

2022-05-30

chg122 (审核中...)

前往app查看评论内容

#局部#

Mil Med：战时烧伤伤员局部治疗新方法研究

2022-05-12

chg122 (审核中...)

前往app查看评论内容

#局部#

Aging Cell：绝经期全身性和局部性肥胖增加研究

2022-05-12

chg122 (审核中...)

前往app查看评论内容

#局部#

Rhizen Pharmaceuticals AG在2022年欧洲肿瘤内科学会乳腺癌会议上公布一项进行中的Tenalisib (RP6530)治疗局部晚期或转移性乳腺癌患者II期研究的中期积极数据

2022-05-08

chg122 (审核中...)

前往app查看评论内容

#局部#

BMC Med：阿帕替尼+奥沙利铂+卡培他滨新辅助治疗局部晚期胃癌/胃食管交界处癌

2022-05-04

chg122 (审核中...)

前往app查看评论内容

#局部#

DCR：扩大右侧结肠切除术不会降低结肠癌局部区域复发的风险

2022-04-24

chg122 (审核中...)

前往app查看评论内容

#局部#

NICE推荐Bavncio (avelumab)治疗局部晚期转移性尿路上皮癌 (UC)

2022-04-19

chg122 (审核中...)

前往app查看评论内容

#局部#

J Dermatolog Treat：局部曲安奈德联合富血小板血浆可更好地治疗瘢痕疙瘩

2022-04-13

chg122 (审核中...)

前往app查看评论内容

#局部#

AACR重磅：局部晚期或转移性胃/GEJ癌患者使用抗TTX-030联合化学免疫疗法的一线治疗的安全性有效性评估

2022-04-12

chg122 (审核中...)

前往app查看评论内容

#局部#

J Allergy Clin Immunol：乌帕替尼+局部皮质激素可有效治疗特应性皮炎，效果至少持续52周

2022-04-11

chg122 (审核中...)

前往app查看评论内容

#局部#

BMC Cancer：局部晚期非小细胞肺癌（LA-NSCLC）放化疗后durvalumab治疗可改善患者的预后

2022-04-09

chg122 (审核中...)

前往app查看评论内容

#局部#

J Dermatolog Treat：激光治疗原发性局部皮肤淀粉样变性的效果如何？

2022-04-07

chg122 (审核中...)

前往app查看评论内容

#局部#

Front Oncol：局部晚期或转移性食管鳞状细胞癌患者在化疗基础上联合放疗可改善患者预后

2022-04-07

科室
- - 订阅+
  - 更多科室
工具
服务